Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29930736
Publication Date : //

Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions.

Reporter gene systems can serve as therapy targets. However, the therapeutic use of reporters has been limited by the challenges of transgene delivery to a majority of cancer cells. This study specifically assesses the efficacy of targeting human somatostatin receptor subtype 2 (hSSTR2) with peptide receptor radionuclide therapy (PRRT) when a small subpopulation of cells bears the transgene. The hSSTR2 transgene was delivered to A549 and Panc-1tumors using the lentiviral vector, LV-hSSTR2-IRES-GFP or murine mesenchymal stem cells (mMSC)s using a retroviral vector. SSTR2 expression was assessed using Western blot and correlated to GFP fluorescence and Ga-DOTATOC uptake. Wild type (WT), transduced (TD), and mixed population A549 or Panc-1 xenografts were implanted in nude mice. Separate groups with A549 and Panc-1 tumors received intratumoral injection of SSTR2-expressing mMSCs. Tumor-bearing mice were treated with Y-DOTATOC or saline and evaluated with Ga-DOTATOC PET before and after treatment. Cell studies showed a strong correlation between Ga-DOTATOC uptake and SSTR2 expression in A549 (p < 0.004) and Panc-1 cells (p < 0.01). Ga-DOTATOC PET SUVmean was 8- and 5-fold higher in TD compared to WT A549 and Panc-1 tumors, respectively (p < 0.001). After Y-DOTATOC treatment, 100% TD and mixed population TD xenografts showed growth cessation while the WT xenografts did not. A549 and Panc-1 tumors with SSTR2-expressing mMSCs treated with Y-DOTATOC showed significantly lower tumor volumes compared to controls (p < 0.05). Ga-DOTATOC PET SUVmean of treated TD tumors monotonically declined and was significantly lower than that of non-treated xenografts. We showed that SSTR2 delivery to a small population of cells in tumor in conjunction with PRRT is effective in tumor growth cessation. The availability of various transgene delivery methods for hSSTR2 and radiotherpaeutic somatostatin analogs highlights the direct translational potential of this paradigm in the treatment of various cancers.

Authors : Heidari Pedram , Kunawudhi Anchisa , Martinez-Quintanilla Jordi , Szretter Alicia , Shah Khalid , Mahmood Umar ,

Related products :

Catalog number Product name Quantity
SSR1_RAT ELISA Kit FOR Somatostatin receptor type 1; organism: Rat; gene name: Sstr1 96T
SSR4_RAT ELISA Kit FOR Somatostatin receptor type 4; organism: Rat; gene name: Sstr4 96T
SSR3_RAT ELISA Kit FOR Somatostatin receptor type 3; organism: Rat; gene name: Sstr3 96T
E2292r ELISA Kit FOR Somatostatin receptor type 2; organism: Rat; gene name: Sstr2 96T
E2293r ELISA Kit FOR Somatostatin receptor type 5; organism: Rat; gene name: Sstr5 96T
SSR1_MOUSE ELISA Kit FOR Somatostatin receptor type 1; organism: Mouse; gene name: Sstr1 96T
E2292m ELISA Kit FOR Somatostatin receptor type 2; organism: Mouse; gene name: Sstr2 96T
SSR3_MOUSE ELISA Kit FOR Somatostatin receptor type 3; organism: Mouse; gene name: Sstr3 96T
SSR4_MOUSE ELISA Kit FOR Somatostatin receptor type 4; organism: Mouse; gene name: Sstr4 96T
E2293m ELISA Kit FOR Somatostatin receptor type 5; organism: Mouse; gene name: Sstr5 96T
GTX30184 Somatostatin Receptor Type 1 100 µl
DP081 Somatostatin Receptor Type 1 1 ml
GTX70677 Somatostatin Receptor Type 4 25 µg
GTX70725 Somatostatin Receptor Type 1 25 µg
GTX71049 Somatostatin Receptor Type 3 25 µg
ARP33359_P050 Somatostatin Receptor Type 4 50 µg
ARP33359_T100 Somatostatin Receptor Type 4 100 µg
DP081 Somatostatin Receptor Type 1 1 ml
DP081-05 Somatostatin Receptor Type 1 0,5 ml
GTX73972 Somatostatin Receptor Type 1 1 ml
MO15109-100 Somatostatin Receptor Type 2 0.1 mg
GTX29550 Somatostatin Receptor Type 2 100 µl
GTX13394 Somatostatin Receptor Type 4 25 µg
GTX13120 Somatostatin Receptor Type 2 25 µg
DP081-05 Somatostatin Receptor Type 1 0,5 ml


GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur

Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur



9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017


france@gentaur.com | Gentaur

Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123

GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U

spain@gentaur.com | Gentaur

ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636

GENTAUR Poland Sp. z o.o.

ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556


Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur